• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 99
 
Full Screen

  • TITLE
  • CERTIFICATE-1
  • CERTIFICATE-2
  • DECLARATION
  • ABSTRACT
  • ACKNOWLEDGEMENT
  • ABBREVIATIONS
  • PREFACE
  • CONTENTS
  • LIST OF FIGURES
  • LIST OF TABLES
  • 1. GENERAL INTRODUCTION
  • 1.1 Medicinal Plants and their present day significance
  • 1.2 Antibiotic resistance acquired by pathogenic microbes
  • 1.3 Secondary metabolites of plants and their medicinalvalues
  • 1.4 Antibacterial properties of plant products
  • 1.5 Pteridophytes and their importance
  • 1.6 Biological activity of Ferns
  • 2. REVIEW OF LITERATURE
  • 2.1 Introduction
  • 2.2 Medicinal Plants and their antibacterial properties
  • 2.3. Phytopharmaceuticals
  • 2.3.1 Phytochemicals from lower group of plants (Lichens) and its biological activity
  • 2.3.2 Phytochemicals from lower group of plants, especially from ferns and its biological activities.
  • 2.3.3 Phytochemicals from Gymnosperms and their biological significance
  • 2.3.4 Phytochemicals from Higher plants especially fromA ngiosperms, a brief report
  • 2.4. Phytopaharmaceuticals from Pteridophytes especially Ferns
  • 2.4.1 Terpenoids from ferns
  • 2.4.2 Flavonoids from Ferns
  • 2.4.3 Glycosides isolated from ferns
  • 2.4.4. Alkaloids isolated from ferns
  • 3. ANTIBACTERIAL AND PHYTOCHEMICAL SCREENING OF FERNS
  • 3.1 Introduction
  • 3.2 Materials and Methods
  • 3.2.1 Procurement of plant materials
  • 3.2.2 Preparation of plant extract
  • 3.2.3 Bacterial strains
  • 3.2.4 Maintenance of bacterial strains
  • 3.2.5. The Inoculum
  • 3.2.6. Mueller-Hinton agar
  • 3.2.7 In vitro antibacterial assay
  • 3.2.8 Plant extracts for second level of evaluation
  • 3.2.9 Bacterial strains for the second level of evaluation
  • 3.2.10 Antibacterial evaluation for the second level of evaluation
  • 3.2.11 Preliminary detection of phytochemicals
  • 3.3 Results and discussion
  • 4. ISOLATION, PURIFICATION AND CHARACTERIZATION OF ANTIBACTERIAL PRINCIPLE FROM DRYNARIA QUERCIFOLIA
  • 4.1 Introduction
  • 4.2 Botany of Drynaria quercifolia
  • 4.3 An outline of the phytochemistry and bioactivity of genusDrynaria
  • 4.4 Materials and Methods
  • 4.4.1 Collection of plant material
  • 4.4.2 Preparation of crude extracts for isolating antibacterialcompound
  • 4.4.3 In vitro antibacterial assay for hot extracts
  • Fig. 4.1. (a) Drynaria quercifolia habit
  • 4.4.4 Preliminary detection of phytochemicals
  • 4.4.5 Separation of the hot extract using Thin Layer Chromatography (TLC)
  • 4.4.6. Selection of suitable solvent system for fractionating acetone extract
  • 4.4.7 Visualisation of substances on chromatogram
  • 4.4.8 Column chromatographic separation
  • 4.4.9. Determination of antibacterial activity of the compound
  • 4.4.10 Preparation of the stock solution of the compound
  • 4.4.11 Determination of the MIC and MBC of the compound
  • 4.4.12 Spectroscopic studies
  • 4.4.13 Statistical analysis
  • 4.5 Results and Discussion
  • 4.5.1 Antibacterial activity of crude extracts
  • Fig. 4.2 (a) Antibacterial activity of different extracts ofD. quercifolia towards Escherichia coli (MTCC-443)
  • Fig.4.2 (b) Antibacterial activity of different extracts ofD.quercifolia towards Staphylococcus aureus (MTCC-96)
  • Fig. 4.2 (c) Antibacterial activity of standard antibiotics (25?g/disc) towards Escherichia coli (MTCC-443)
  • Fig.4.2 (d) Antibacterial activity of standard antibiotics (25 ?g/disc) towards Pseudomonas aeruginosa (MTCC-741)
  • Fig.4.2 (e) Yellow fluorescence spots in long wave U.V light
  • Fig.4.2 (f) Dark brown colour after spraying undiluted Folinciocalteu reagent indicates phenols in acetoneextract of D. quercifolia
  • 4.5.2 Fractions separated from D. quercifolia using column chromatography
  • 4.5.3 Characterization of active principle
  • 4.5.4 Inferences of spectral analysis
  • 4.5.5 Antibacterial activity of compound
  • Fig.4.4 (a) Antibacterial activity of the compound (X) towardsS. aureus; the control disc marked as (C)
  • Fig. 4.5. (a) Minimum Inhibitory Concentration (MIC) of the compound towards Staphylococcus aureus (MTCC-96); 10th test tubeas control; up to 5th tube no visible growth.
  • 5. MODE OF ACTION OF THE COMPOUND
  • 5.1 Introduction
  • 5.2 Structurally similar compounds and their reported properties
  • 5.3 Mode of action of non-antibiotic antibacterial agents
  • 6. SUMMARY AND CONCLUSION
  • BIBLIOGRAPHY